Showing 5831-5840 of 5956 results for "".
- The Foundation Fighting Blindness Presents the Emerging Science Showcase at OIS Retina 2018https://modernod.com/news/the-foundation-fighting-blindness-presents-the-emerging-science-showcase-at-ois-retina-2018/2480012/The Foundation Fighting Blindness (FFB) Emerging Science Showcase will lead off the upcoming Ophthalmology Innovation Summit for Retina, held July 20, 2018, in Vancouver, B.C., Canada. Moderated by FFB COO Jaso
- Sheraz Daya, MD, Introduces the Daya ICL Forcepshttps://modernod.com/news/sheraz-daya-md-introduces-the-daya-icl-forceps/2480015/In partnership with MST, Sheraz Daya, MD, has co-created an ICL loading system that ensures true confidence in loading and positioning. The design of the forceps allow the user to pull the ICL into the injection cartr
- RETINA-AI Releases the First Artificial Intelligence Mobile App for Eye Care Providershttps://modernod.com/news/retina-ai-releases-the-first-artificial-intelligence-mobile-app-for-eye-care-providers/2480018/RETINA-AI has developed and released the first artificial intelligence mobile app for eye care providers. The app, called Fluid Intelligence by RETINA-AI, detects macular edema and subretinal fluid on OCT retinal scans with greater than 90% accuracy, according to a company news release. Fl
- Practice-Hospital Consolidation Increasing for Many Specialtieshttps://modernod.com/news/practice-hospital-consolidation-increasing-for-many-specialties/2480021/The level of integration of certain primary care practices into health systems and hospitals more than doubled in recent years, with steeper increases seen in the fields of oncology and cardiology, according to research publish
- Zeiss Names New Chief Financial Officerhttps://modernod.com/news/zeiss-names-news-chief-financial-officer/2480025/Christian Müller, PhD, will become Chief Financial Officer of Carl Zeiss AG, succeeding Thomas Spitzenpfeil who, as previously announced, will leave the company. Dr. Müller has been CFO of the Zeiss subsidiary Carl Zeiss Meditec AG since 2009. He joined the Zeiss Group in 2002 as head of Corporat
- Lightmed Announces New Office Location in Caesarea, Israelhttps://modernod.com/news/lightmed-announces-new-office-location-in-caesarea-israel/2480027/Lightmed announced it has opened a new office location in Caesarea, Israel to expand its business and technological investments, and leverage Israel’s diverse and experienced medical technology talent pool. “Th
- Oyster Point Announces Positive Results from Phase 2 Clinical Trial of Investigational Treatment for Dry Eye Diseasehttps://modernod.com/news/oyster-point-pharma-announces-positive-results-from-phase-2-clinical-trial-of-investigational-treatment-for-dry-eye-disease/2480029/Oyster Point Pharma announced results from the PEARL study, a phase 2b clinical trial evaluating the company’s novel therapy for the treatment of dry eye disease (DED). The study met both sign and symptom primary endpoints by showing a statistically significant improvement in each compared to a v
- Some AMD Patients May Not Respond to Intravitreal Aflibercepthttps://modernod.com/news/some-amd-patients-may-not-respond-to-intravitreal-aflibercept/2480030/Although intravitreal aflibercept is effective in the great majority of treatment-naive cases of neovascular age-related macular degeneration (AMD), the drug may not work for a small subgroup of patients with choroidal vascular hyperpermeability, Japanese researchers say, according to a
- Some Companies Cancel, Reduce Planned Price Hikes Amid Continued Pressure Over US Drug Costs: Reporthttps://modernod.com/news/some-companies-cancel-reduce-planned-price-hikes-amid-continued-pressure-over-us-drug-costs-report/2480031/Novartis, Gilead Sciences, Roche, and Novo Nordisk have advised California health plans in recent weeks that the companies are rescinding or reducing previously announced price increases on at least 10 drugs, Bloomberg reported Tuesday. The moves come after California introduced legislation earli
- Oculocare’s Alleye Receives FDA 510(k) Clearance for Monitoring Eyesight in AMDhttps://modernod.com/news/oculocares-alleye-receives-fda-510k-clearance-for-monitoring-eyesight-in-amd/2480036/Oculocare Medical announced the FDA 510(k) clearance of Alleye, a mobile medical software application indicated for the detection and monitoring of age-related macular degeneration (AMD). Alleye is designed to detect and characterize central and paracentral metamorphopsia (visual distortio